Fool.com
The World's Greatest Investing Community
Results 1 - 10 of 425 : 1 2 3 4 5 6 7 8 9 Next
A Little Distracted, Are You, Merck?
The FDA rejects its latest application.
These stocks are reaching for the stars.
Pharma Researchers Need a Cure
As the industry changes, Pharmaceutical Product Development and Parexel International struggle.
Pfizer's and Merck's Loss Is These Companies' Gain
Too busy integrating to take advantage of additional acquisitions.
A Big Upgrade for Electro-Optical Sciences
This bullish call comes from more than just one analyst.
Taking the Drug Industry's Temperature
Covance and Icon hint at broader pharmaceutical R&D trends.
Merck-Schering Doesn't Look So Good
Revenue is stagnant; let's hope that pipeline pans out.
Nibbles Here and There at Forest Labs
Forest Laboratories banks on its usual strategy to offset generic-drug threats.
Foolish Forecast: A Last Look at "Mini" Pfizer
Views you can use to get clues on tomorrow's news.
A Smart Way to Fund Health Care?
Is a soda tax fair? Would it even work?
Legal Information © 1995 - 2009 The Motley Fool. All rights reserved.
Market Data provided by 
Terms & Conditions
RSS Headlines
Fool UK